Search Results

Drospirenone (Slynd) - a new progestin-only oral contraceptive.

Subjects: Androstenes/Androstenes/Androstenes/*therapeutic use ; Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/*therapeutic use ; Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/*therapeutic use

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2020 Feb 10; Vol. 62 (1591), pp. 18-19.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens.

• Authors : Simon JA; Symons JP ...

Subjects: Estrogen Replacement Therapy*/Estrogen Replacement Therapy*/Estrogen Replacement Therapy*/adverse effects; Estradiol Congeners/Estradiol Congeners/Estradiol Congeners/*pharmacology ; Estrogens, Conjugated (USP)/Estrogens, Conjugated (USP)/Estrogens, Conjugated (USP)/*pharmacology

• Source: Menopause (New York, N.Y.) [Menopause] 2001 Sep-Oct; Vol. 8 (5), pp. 321-7.Publisher: Lippincott-Raven Publishers Country of Publication: United States NLM ID: 9433353 Publication Model: Print Cited Medium: Print ISSN:

Record details

Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.

• Authors : Notelovitz M; Women's Health Center and Rhône-Poulenc Rorer Pharmaceuticals Inc, Colllegeville, PA, USA.; Cassel D

Subjects: Estrogen Replacement Therapy* ; Menopause* ; Sweating*

• Source: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2000 Jan; Vol. 182 (1 Pt 1), pp. 7-12.Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print Cited Medium: Print ISSN: 0002-9378 (Print)

Record details

Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss.

• Authors : Roux C; Centre d'Evaluation des Maladies Osseuses, Département de Rhumatologie, Hôpital Cochin, Université René Descartes, Paris, France. ; Pelissier C

Subjects: Androgen Antagonists/Androgen Antagonists/Androgen Antagonists/*therapeutic use ; Estradiol/Estradiol/Estradiol/*therapeutic use ; Norethindrone/Norethindrone/Norethindrone/*therapeutic use

• Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print Cited Medium: Print ISSN: 0937-941X

Record details

Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.

• Authors : Trapnell CB; Food and Drug Administration, Rockville, USA. ; Donahue SR

Subjects: Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/*pharmacokinetics ; Estradiol Congeners/Estradiol Congeners/Estradiol Congeners/*pharmacokinetics ; Ethinyl Estradiol/Ethinyl Estradiol/Ethinyl Estradiol/*pharmacokinetics

• Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 1998 Dec; Vol. 64 (6), pp. 597-602.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print Cited Medium: Print ISSN: 0009-9236 (Print)

Record details

Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women.

• Authors : Singh M; The New York Hospital-Cornell University Medical College, New York City, USA.; Saxena BB

Subjects: Norethindrone/Norethindrone/Norethindrone/*blood ; Progesterone Congeners/Progesterone Congeners/Progesterone Congeners/*blood; Adolescent

• Source: Contraception [Contraception] 1997 Jan; Vol. 55 (1), pp. 23-33.Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print Cited Medium: Print ISSN: 0010-7824 (Print)

Record details

The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation.

• Authors : Ditkoff EC; Department of Obstetrics and Gynecology, Columbia-Presbyterian Medical Center, Columbia University, New York, New York 10032, USA.; Prosser R

Subjects: Leuprolide/Leuprolide/Leuprolide/*therapeutic use ; Norethindrone/Norethindrone/Norethindrone/*analogs & derivatives ; Ovulation Induction/Ovulation Induction/Ovulation Induction/*methods

• Source: Journal of assisted reproduction and genetics [J Assist Reprod Genet] 1997 Feb; Vol. 14 (2), pp. 92-6.Publisher: Springer Country of Publication: Netherlands NLM ID: 9206495 Publication Model: Print Cited Medium: Print ISSN: 1058-0468 (Print)

Record details

Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.

• Authors : Weber-Diehl F; Department of Fertility Control, Schering AG, Berlin, Germany.; Lehnert J

Subjects: Contraceptives, Oral, Combined/Contraceptives, Oral, Combined/Contraceptives, Oral, Combined/*pharmacology ; Menstrual Cycle/Menstrual Cycle/Menstrual Cycle/*drug effects ; Norethindrone/Norethindrone/Norethindrone/*pharmacology

• Source: Contraception [Contraception] 1993 Oct; Vol. 48 (4), pp. 291-301.Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print Cited Medium: Print ISSN: 0010-7824 (Print)

Record details

Effect of norethindrone acetate in the treatment of symptomatic endometriosis.

• Authors : Muneyyirci-Delale O; Department of Obstetrics and Gynecology, SUNY/Health Science Center at Brooklyn, USA.; Karacan M

Subjects: Endometriosis/Endometriosis/Endometriosis/*drug therapy ; Norethindrone/Norethindrone/Norethindrone/*therapeutic use ; Progesterone Congeners/Progesterone Congeners/Progesterone Congeners/*therapeutic use

• Source: International journal of fertility and women's medicine [Int J Fertil Womens Med] 1998 Jan-Feb; Vol. 43 (1), pp. 24-7.Publisher: Medical Science Pub. International Country of Publication: United States NLM ID: 9706778 Publication Model: Print Cited Medium: Print

Record details

Norethindrone--a review of therapeutic applications.

• Authors : Taitel HF; Ortho-McNeil Pharmaceutical Raritan, New Jersey, USA.; Kafrissen ME

Subjects: Climacteric/Climacteric/Climacteric/*drug effects ; Climacteric/Climacteric/Climacteric/*physiology ; Menopause/Menopause/Menopause/*physiology

• Source: International journal of fertility and menopausal studies [Int J Fertil Menopausal Stud] 1995 Jul-Aug; Vol. 40 (4), pp. 207-23.Publisher: Medical Science Pub. International, Inc Country of Publication: United States NLM ID: 9309760 Publication Model: Print Cited Medium: Print

Record details